This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4bb6
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4bb6' size='340' side='right'caption='[[4bb6]], [[Resolution|resolution]] 2.55Å' scene=''> | <StructureSection load='4bb6' size='340' side='right'caption='[[4bb6]], [[Resolution|resolution]] 2.55Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4bb6]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[4bb6]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BB6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4BB6 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=HD1:6-(4-METHYLPIPERAZIN-1-YL)-N-[(1R,3S)-5-OXIDANYL-2-ADAMANTYL]-2-PROPYLSULFANYL-PYRIDINE-3-CARBOXAMIDE'>HD1</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.55Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=HD1:6-(4-METHYLPIPERAZIN-1-YL)-N-[(1R,3S)-5-OXIDANYL-2-ADAMANTYL]-2-PROPYLSULFANYL-PYRIDINE-3-CARBOXAMIDE'>HD1</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene></td></tr> | |
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4bb6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4bb6 OCA], [https://pdbe.org/4bb6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4bb6 RCSB], [https://www.ebi.ac.uk/pdbsum/4bb6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4bb6 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4bb6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4bb6 OCA], [https://pdbe.org/4bb6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4bb6 RCSB], [https://www.ebi.ac.uk/pdbsum/4bb6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4bb6 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | + | [https://www.uniprot.org/uniprot/DHI1_HUMAN DHI1_HUMAN] Defects in HSD11B1 are a cause of cortisone reductase deficiency (CRD) [MIM:[https://omim.org/entry/604931 604931]. In CRD, activation of cortisone to cortisol does not occur, resulting in adrenocorticotropin-mediated androgen excess and a phenotype resembling polycystic ovary syndrome (PCOS). | |
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/DHI1_HUMAN DHI1_HUMAN] Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone. Catalyzes reversibly the conversion of 7-ketocholesterol to 7-beta-hydroxycholesterol. In intact cells, the reaction runs only in one direction, from 7-ketocholesterol to 7-beta-hydroxycholesterol (By similarity). | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 29: | Line 28: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | + | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Bennett | + | [[Category: Bennett SNL]] |
| - | [[Category: Bodin | + | [[Category: Bodin C]] |
| - | [[Category: Donald | + | [[Category: Donald CS]] |
| - | [[Category: Goldberg | + | [[Category: Goldberg FW]] |
| - | [[Category: Groombridge | + | [[Category: Groombridge SD]] |
| - | [[Category: | + | [[Category: Gyte AC]] |
| - | [[Category: | + | [[Category: Leach AG]] |
| - | [[Category: | + | [[Category: Morentin Gutierrez P]] |
| - | [[Category: Scott | + | [[Category: Scott JS]] |
| - | [[Category: Snelson | + | [[Category: Snelson WL]] |
| - | + | ||
| - | + | ||
Current revision
Free-Wilson and Structural Approaches to Co-optimising Human and Rodent Isoform Potency for 11b-Hydroxysteroid Dehydrogenase Type 1 11b-HSD1 Inhibitors
| |||||||||||
